Piper uses AI-generated videos to promote their compounded GLP-1 medications, and while this isnt necessarily surprising, Im always left wondering if that works
As GLP-1 agonists have garnered attention for management of obesity due to their effect on reducing insulin sensitivity, they are now being considered a therapeutic option for the treatment of PCOS (polycystic ovarian syndrome), one of the most common causes of subfertility, diagnosed via Rotterdams criteria: oligomenorrhea, hyperandrogenism and polycystic ovaries (97)
Patients typically lose 13 pounds per week, but results vary
Moreover, in 2000, a peer-reviewed Neurology study discovered that ALCAR showed signs of being able to slow the decline of patients with the most common type of dementia, early-onset Alzheimer's disease
Addressing this side effect would substantially improve the feasibility of employing GLP-1 analogs for opioid withdrawal treatment